Somerville, MA, United States of America

Jason Fox

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Levisense Medical, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Fox. Retrieved from https://idiyas.com/inventor/jason-fox-msvb3106

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason Fox - Innovator in Medical Technology

Introduction

Jason Fox is an accomplished inventor based in Somerville, MA (US). He is currently associated with Levisense Medical, Inc., where he contributes to advancements in medical technology. Despite having no patents to his name, his work in the field is noteworthy.

Latest Patents

As of now, Jason Fox has not registered any patents. However, his innovative ideas and contributions to the medical technology sector are significant.

Career Highlights

Jason has built a career focused on improving healthcare solutions. His role at Levisense Medical, Inc. allows him to work on cutting-edge projects that aim to enhance patient care and medical practices.

Collaborations

Jason collaborates with talented individuals such as David Bertoni and Matthew Culen. Together, they work towards innovative solutions in the medical field.

Conclusion

Jason Fox is a dedicated inventor whose contributions to medical technology are valuable, even in the absence of patents. His work at Levisense Medical, Inc. and collaborations with colleagues highlight his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…